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Abstract
Prevention of fragility fractures in older people has become a public health priority, although the 
most appropriate and cost-effective strategy remains unclear. In the present statement, the Interest 
Group on Falls and Fracture Prevention of the European Union Geriatric Medicine Society 
(EUGMS), in collaboration with the International Association of Gerontology and Geriatrics for 
the European Region (IAGG-ER), the European Union of Medical Specialists (EUMS), the 
International Osteoporosis Foundation - European Society for Clinical and Economic Aspects of 
Osteoporosis and Osteoarthritis, outlines its views on the main points in the current debate in 
relation to the primary and secondary prevention of falls, the diagnosis and treatment of bone 
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fragility, and the place of combined falls and fracture liaison services for fracture prevention in 
older people.
Keywords
Falls; fragility fracture; older people; prevention; position statement
Introduction
Three quarters of all vertebral and non-vertebral fractures occur among adults aged 65 years 
or older and over three quarters of hip fractures occur in people aged 75 or over (1). The 
major influence of ageing on fracture risk is mainly due to the strong impact of age and age-
related conditions on bone strength and fall risk (2, 3). Although fractures of the hip are the 
most serious and costly fractures, those at the spine, pelvis, distal femur, proximal tibia, 
proximal humerus, and ribs are also major fractures, associated with excess morbidity and 
mortality, increased hip fracture risk, decreased quality of life, and high health care costs (4–
8). With the global growth of the older population, prevention of fractures has become an 
international public health priority (4, 9, 10). The most appropriate and cost-effective 
strategy to prevent major fractures in older people however remains a hotly debated topic 
(11–14). In the present statement, the Interest Group on Falls and Fracture Prevention of the 
European Union Geriatric Medicine Society (EUGMS), in collaboration with the 
International Association of Gerontology and Geriatrics for the European Region (IAGG-
ER), the European Union of Medical Specialists (EUMS), the International Osteoporosis 
Foundation - European Society for Clinical and Economic Aspects of Osteoporosis and 
Osteoarthritis, outlines its views on the main points in the current debate.
Primary and secondary prevention related to falls
In adults, falls occur predominantly in older people. In populations over age 65, a third of 
community-dwelling people fall at least once per year and in those aged 80 years or more a 
non-vertebral fractures result from a fall (2, 3). Around 10% of falls result in a fracture (17, 
18) and 2% in a hip fracture (19). The efficacy of falls prevention interventions to reduce 
fractures is debated (13, 14), in part because it depends on the fall risk profile of people and 
the type of intervention program (20, 21).
There is no international consensus for assessing the fall risk profile of older people, even if 
it is well understood that people at higher risk of future falls are those aged 75 or older, those 
who have fallen during the previous 12 months or those who have fear of falling or 
significant gait, muscle strength, or balance problems (16, 22–28). The fall risk profile is 
also dependent on the setting and some other factors, including cognitive impairment which 
may be associated with increased risk-taking. Even though balance, gait, and muscle 
function decline increases the risk of falling, the relationship is not completely linear since 
those with most problems (i.e. bedridden) usually have a lower falls risk, similar to those 
without such problems, presumably due to low exposure to risk (29).
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Notwithstanding the lack of consensus in assessing fall risk profile, there is rather consistent 
evidence in subjects with low to moderate falls risk, usually community dwelling, that 
multicomponent exercise programs, including progressive, challenging and regular exercises 
designed to improve balance, muscle strength, and protective responses in case of 
destabilisation, are effective in the reduction of serious falls and non-vertebral fractures (21, 
24, 30, 31). The studies are however insufficiently powered to demonstrate a significant 
effect on hip fracture risk (21, 24, 30). Single interventions including treatment of some 
vision problems or carotid sinus hypersensitivity, vitamin D supplementation in deficient 
patients, gradual withdrawal of psychotropic medication, or improving the safety of indoor 
activities and outdoor walking environments are also effective for suitable patient groups in 
the prevention of falls, but the effect on fracture risk is not clear (21, 32, 33). Multifactorial 
interventions, a combination of interventions linked to the individual’s risk profile, seem no 
more effective in preventing falls than single targeted interventions (e.g. community exercise 
or fall prevention programs) (21, 34).
In people at high risk of falls single targeted interventions seem less effective, e.g. in older 
nursing home residents, the only single intervention that has reduced falls is vitamin D 
supplementation (20). Other interventions have been ineffective or inconsistent for falls 
although the rate of recurrent falls may be reduced (35). A multifactorial and 
interprofessional approach, determined by individual assessment of functional, medical, and 
social concerns, may be a more appropriate strategy to prevent falls in older people at high 
risk of falling (20, 22–34, 36). Moreover, this tailored approach (37) may provide 
opportunities to address previously unidenti ed health problems (e.g. impaired cognition, 
diabetes, Parkinson’s disease, osteoporosis) (9, 38), conferring bene ts beyond falls 
prevention (39, 40). People at high risk of fall are most often frail patients (40) and 
multifactorial approach in this population has been shown to improve the ability to live 
safely and independently (41).
Taken together, the EUGMS supports 1) the set-up of a working group that would develop 
consensus international operational definitions and diagnostic criteria for assessing the risk 
of falling to be used in clinical practice as well as in research studies, 2) the 2010 American 
Geriatrics Society / British Geriatrics Society joint guideline urging practitioners to screen, 
at least annually, older patients for risk of falling (42), 3) that above evidenced-based 
measures, especially evidence-based community exercise fall prevention programs, should 
be widely available to prevent non-vertebral fractures in older people at low or moderate risk 
of falling (9), and 4) that people at high risk should be able to access individually tailored 
multifactorial measures based on a comprehensive geriatric assessment. EUGMS 
recommends continued and expanded provision of evidence based fall prevention 
programmes such as those being promoted by ProFouND (www.profound.eu.org).
Primary and secondary prevention related to bone health
It is widely recognized that lifestyle measures (regular weight-bearing exercises, balanced 
diet, including calcium intake, avoiding smoking and excessive alcohol consumption) and 
measures aimed at reducing adverse effects on bone of drugs and diseases, including renal 
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diseases, have to be recommended throughout life in everyone. They are beneficial in 
optimizing skeletal development (43–46) and limiting bone loss during adulthood (47).
Whereas there are well established definitions of osteoporosis (13, 14), there is much current 
debate on what is the target population that may potentially benefit from treatments acting 
on bone metabolism (TABM) (13, 14, 48–51).
Osteoporosis is currently defined by bone densitometry (densitometry osteoporosis) when 
the bone mineral density (BMD) is 2.5 SD or more below that of the mean level for a young-
adult reference population (T-score ≤-2.5 at the lumbar spine or the hip, or at the distal 
radius when the hip and lumbar spine cannot be measured or are unusable or 
uninterpretable) (52–54). Aortic calcification and osteoarthrosis that increase progressively 
with age may be a source of accuracy error in the measurement of lumbar spine BMD in 
older people (55, 56). However, for a given BMD, the risk of major fractures depends on 
other risk factors for bone fragility, of which age is the most important one, which are taken 
into account in different fracture prediction tools such as the most used FRAX® tool 
(www.shef.ac.uk.FRAX) or the Garvan Fracture Risk calculator (www.garvan.org.au/bone-
fracture) or the Q-fracture Risk Calculator (www.qfracture.org). Fragility fracture risk 
should therefore take into account not only BMD but also other risk factors of bone fragility, 
by using fracture prediction tools, and falls risk (57). Since falls and osteoporosis are 
independent risk factors of non-vertebral fractures, osteoporosis should induce bone fragility 
but also in patients at risk of falls and vice versa (58). The prevalence of osteoporosis 
detected by DXA BMD measurement is high in fallers with sarcopenia, impaired mobility, 
and weight loss, which are risk factors for both falls and osteoporosis (58).
A fracture is considered a fragility or low energy fracture when it is the result of a minimal 
trauma, such as a fall from a standing height or less. However, a fall from standing height 
without any protective response generates an amount of energy which is at least 10 times the 
energy required to fracture the proximal femur of an elderly woman (59). Diagnosis of 
fragility fracture should therefore be set after a careful comprehensive assessment including 
1) Fracture mechanism consideration (energy of the trauma) and 2) bone strength estimate, 
based on bone mineral density (BMD), considering that densitometry osteoporosis is 
observed in around 60% and 40% hip fractured women and men, respectively (60), fracture 
type (comminuted or not, for example) and operator’s subjective assessment of bone quality 
in the case of surgery.
The cost-effectiveness of the pharmacological approach of treating osteoporosis (and 
therefore on searching for osteoporosis by Dual-Energy X-Ray Absorptiometry (DXA)) is 
also debated (13). However, several licensed TABM have shown their ability to prevent 
major fractures in people (most often women) with a T-score ≤-2.5 at the spine or the hip 
(raloxifene has only been shown effective in preventing vertebral fractures) (14, 61) or after 
a hip fracture (61). Relative risk reductions of spine and non-vertebral fractures by TABM in 
subjects with bone densitometry diagnosed osteoporosis are 40–60% and 20–40%, 
respectively (14, 61). Number-Needed-to-Treat (NNT) to prevent a fracture is lower in 
people at high risk of fractures, and especially in those with prior fragility fractures (13, 37, 
61–73).
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Taken together, EUGMS supports recommendations that 1) osteoporosis should be 
ascertained by DXA, at best combined with vertebral fracture assessment (VFA) or 
radiography examination to detect vertebral fractures, in individuals at risk of fracture, i.e. at 
risk of falling (58) or at risk of bone fragility (history of fracture, low body weight, parental 
history of hip fracture, use of glucocorticoids, excessive alcohol consumption, diseases with 
bone adverse effects) (74), 2) TABM should be considered after a careful assessment of the 
benefit/risk ratio in patients at high risk of fracture, i.e. with a prior fragility fracture or in 
those with densitometry diagnosed osteoporosis associated with other risks factors of 
fractures, assessed both by fracture prediction scores and risk of falling 3) TABM should not 
be initiated when the life expectancy is less than 6–12 months, the minimum time needed for 
drugs to be effective in fracture prevention (66).
EUGMS recommends that prospective studies be conducted in non-selected older people 
(particularly in those aged over 80 years) to determine if this strategy is effective, 
considering that age and health status may modify compliance to treatments and the 
Number-to-Treat/Number-Needed-to-Harm (NNH) of TABM (61).
Fracture Liaison Services and screening for spine fragility
As the diagnosis of fragility fracture and the assessment of benefit/risk ratio of the above 
measures is complex, EUGMS recommends that patients aged 65 years or older with 
vertebral or non-vertebral fractures should be referred to a fracture liaison service (FLS) (as 
proposed by the International Osteoporosis Foundation in the Capture the Fracture initiative) 
(75), which should be linked to or have strong input from geriatric medicine services 
(combined fall and fracture liaison service). Such an approach will allow commencement of 
appropriate interventions and ensure locally agreed arrangements for follow-up of patients. 
This model of care has been shown to be cost-effective (76, 77).
EUGMS emphasizes that vertebral compression fractures are common, and often 
unrecognized in older people. X-ray examination should be more systematically performed 
in older patients with back pain, significant height loss (e.g. 5 cm or more), or significant 
incident kyphosis. Radiologists should be encouraged to report on the presence or absence 
of vertebral deformities as “fractures” when assessing chest radiographs so as to identify 
patients who need referral to the combined fall and fracture liaison services (78), as these are 
mostly fragility fractures in older people (53).
Conclusion
EUGMS advocates a comprehensive and multidisciplinary fracture prevention strategy in 
individuals aged 65 or older requiring: 1) Better education for both older people and health 
care professionals with regards to general lifestyle and medical measures to optimize bone 
health and prevent falls; 2) Improved knowledge about screening and optimizing 
management of older people with bone fragility or high risk of falling in primary and 
community care as well as institutional settings; and 3) Strong collaboration between 
fracture liaison services, geriatric medicine departments (combined falls and fracture liaison 
services) and primary care. Policy makers will need to play a major role in developing 
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community and institutional programs on falls prevention, to establish falls and fracture 
liaison services and appropriate pathways for fracture prevention that include both 
assessment and management of fallers and optimising medical management in those with 
bone fragility to reduce fracture risk.
The EUGMS believes strongly that the focus for fracture prevention should not be polarised 
into either falls prevention or improving bone health camps. Rather the ideal strategy should 
be on optimising bone health, especially in those with bone fragility, in addition to 
implementing measures to prevent falls.
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